HOUSTON, July 7 /PRNewswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX)
today announced that Greg Browne, Chief Financial Officer, will present at the
Collins Stewart Fourth Annual Growth Conference in New York City on
Wednesday, July 9, 2008 at 1:00 PM EDT. Presentation slides will be available
on-line at http://www.cyberonics.com by 8:00 AM EDT on Wednesday,
July 9, 2008. Collins Stewart will host a webcast of the presentation live
and by replay at http://www.wsw.com/webcast/clst/cybx/. The replay will be
available for 90 days following the conference. The presentation can also be
accessed at http://www.cyberonics.com by clicking on the link for this
webcast. Access to the webcast is not password protected.
ABOUT VNS THERAPY AND CYBERONICS
Cyberonics, Inc. (NASDAQ:CYBX) is a medical technology company with core
expertise in neuromodulation. The company developed and markets the Vagus
Nerve Stimulation (VNS) Therapy(TM) System, which is FDA-approved for the
treatments of refractory epilepsy and treatment-resistant depression. The VNS
Therapy System uses a surgically implanted medical device that delivers pulsed
electrical signals to the vagus nerve. Cyberonics markets the VNS Therapy
System in selected markets worldwide.
Additional information on Cyberonics, Inc. and VNS Therapy(TM) is
available at http://www.cyberonics.com and http://www.vnstherapy.com.
CONTACT INFORMATION:
Greg Browne, CFO
Cyberonics, Inc.
100 Cyberonics Blvd.
Houston, TX 77058
Main: (281) 228-7262
Fax: (281) 218-9332
ir@cyberonics.com
SOURCE Cyberonics, Inc.
